GLP-1
US$ 22.19
glp-1 news today november 6 2025 New in the 6, 2025, issue of NEJM: Survival after Chest-Wall Irradiation in Breast Cancer (SUPREMO phase 3 trial) Oral Icotrokinra for Plaque Psoriasis (ICONIC-LEAD phase 3 trial) 🚨 Breaking News in Obesity
Description
Experts suggest a quick "rebound" effect in appetite and metabolism after stopping the drug, compounded by the stress of pregnancy
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide
Discover how Retatrutide works through its triple-pathway mechanism (GLP-1, GIP, glucagon), how it affects metabolism, and when results may begin.
Popular GLP-1 weight-loss injections like Ozempic or WeGovy are now delivering greater value, according to a new report
